Exact Mass: 766.3285886

F 10863A

Squalene synthase inhibitor compd. A

C41H50O14 (766.32004)

OKODiA-PI

1-(9Z-octadecenoyl)-2-(5-oxo-7-carboxy-6E-heptenoyl)-sn-glycero-3-phospho-(1-myo-inositol)

Glucoscilliroside

3-O-(4-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)-6beta-acetoxy-3beta,8beta,14beta-trihydroxybufa-4,20,22-trienolide

C34H54N8O10S (766.3683424000001)

Strychnine

C42H46N4O8S (766.3036196)

Neurokinin A(4-10)

N,N-Bis(2,5-di-tert-butylphenyl)-3,4,9,10-perylenedicarboximide

C52H50N2O4 (766.377038)

N-T-BOC-ILE-GLU-GLY-ARG 7-AMIDO-4-METHYL-COUMARIN HYDROCHLORIDE

C34H51ClN8O10 (766.3416496000001)

Saquinavir mesylate

C39H54N6O8S (766.3723644000002)

D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065692 - Cytochrome P-450 CYP3A Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D000084762 - Viral Protease Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors

MK-5172

Grazoprevir

C38H50N6O9S (766.3359810000001)

J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AP - Antivirals for treatment of hcv infections D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

3,3-[5,5-Bis[3-(4-pyridinyl)phenyl][1,1:3,1:3,1-quaterphenyl]-3,3-diyl]bispyridine

C56H38N4 (766.3096308)

cyanoethyl sucrose

C36H46N8O11 (766.3285886)

Bisphenol A Phosphite

C45H51O9P (766.3270526)

5, 5-[(2R, 5R)-1-[3,5-difluoro-4-(4-(4-fluorophenyl)- 1-piperidinyl)phenyl]-2,5-pyrrolidinediyl]bis[6-fluoro-2-(2S)-2-pyrrolidinyl 1H-benzimidzole]

C43H43F5N8 (766.3530658)

capreomycin

C25H46N14O12S (766.3140196)

Boc-Met-Asp-Gly-Cys-Glu-Leu-OH

C30H50N6O13S2 (766.287713)

oleandomycin 2-O-phosphate(1-)

C35H61NO15P- (766.3778626)

Bryostatin 11

C39H58O15 (766.3775518)

Phosphoviomycin

C25H45N13O13P+ (766.299727)

(1S,4S,7R,8S,11S,15S,18S,21R,22S,25S)-11-benzyl-4-[(2S)-butan-2-yl]-7,21,25-trimethyl-18-propan-2-yl-6,20-dioxa-13,27-dithia-3,10,17,24,29,30,31,32-octazapentacyclo[24.2.1.15,8.112,15.119,22]dotriaconta-5(32),12(31),19(30),26(29)-tetraene-2,9,16,23-tetrone

(1S,4S,7R,8S,11S,15S,18S,21R,22S,25S)-11-benzyl-4-[(2S)-butan-2-yl]-7,21,25-trimethyl-18-propan-2-yl-6,20-dioxa-13,27-dithia-3,10,17,24,29,30,31,32-octazapentacyclo[24.2.1.15,8.112,15.119,22]dotriaconta-5(32),12(31),19(30),26(29)-tetraene-2,9,16,23-tetrone

C37H50N8O6S2 (766.3294560000002)

Veraguamide A

C37H59BrN4O8 (766.3516034)

A natural product found in Symploca hydnoides and Oscillatoria margaritifera PAC-17-FEB-10-2.

O-Phosphoviomycin

C25H45N13O13P+ (766.299727)

[(1R,2R,3R,4R,6R,8S,12S,13S,14R,15S)-3,4,12,13-tetraacetyloxy-6-hydroxy-4,8,11,11-tetramethyl-15-(2-methylpropanoyloxy)-7,18-dioxo-19-oxatricyclo[13.4.0.02,6]nonadec-9-en-14-yl] 2-methylpropanoate

[1-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

SQDG 30:8;O

C39H58O13S (766.3597938)

PG 22:6/11:3;O3

PG 33:9;O3

LPIM1 19:5

C34H55O17P (766.317671)

PI 14:1/12:3;O3

PI 18:1/8:3;O3

PI 18:2/8:2;O3

C38H55O14P (766.3329259999999)

PI 22:6/7:3;O

PI 29:9;O

C38H55O14P (766.3329259999999)

PI 30:8

7-{[3,4-dihydroxy-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3a-hydroxy-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl acetate

7-{[3,4-dihydroxy-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3a-hydroxy-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl acetate